Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02220894 |
|---|---|
| Brief Title: | Study of Pembrolizumab (MK-3475) Versus Platinum-Based Chemotherapy for Participants With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Advanced or Metastatic Non-Small Cell Lung Cancer (MK-3475-042/KEYNOTE-042) |
| First Submitted : | August 19, 2014 |
| First Submitted that Met QC Criteria : | August 19, 2014 |
| First Posted : | August 20, 2014 (Estimate) |
| Results First Submitted : | February 14, 2019 |
| Results First Submitted that Met QC Criteria : | March 14, 2019 |
| Results First Posted : | March 15, 2019 |
| Last Update Submitted that Met QC Criteria : | October 6, 2023 |
| Last Update Posted : | October 10, 2023 |